| 1 |
35177245 | Retraction notice to "Empagliflozin and neohesperidin mitigate methotrexate hepatotoxicity via Nrf2/PPARγ/HO-1 signalling initiation and suppression of NF-κB/Keap1/HSP70/caspase-3 axis in rats" [Life Sci. 278 (2021) 119638]. | 2022 Apr 1 |
1 |
| 2 |
34051216 | RETRACTED: Empagliflozin and neohesperidin mitigate methotrexate hepatotoxicity via Nrf2/PPARγ/HO-1 signalling initiation and suppression of NF-κB/Keap1/HSP70/caspase-3 axis in rats. | 2021 Aug 1 |
1 |
| 3 |
34768942 | In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia. | 2021 Oct 26 |
1 |